Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer, Hematological”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00500578
What this trial is testing

Intermittent Use of Aerosolized Ribavirin for Treatment of RSV

Who this might be right for
Hematological Malignancies
M.D. Anderson Cancer Center 51
Early research (Phase 1)WithdrawnNCT00009815
What this trial is testing

Combination Chemotherapy in Treating Patients With Advanced Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
University of Pittsburgh
Testing effectiveness (Phase 2)Study completedNCT01246206
What this trial is testing

Tacrolimus and Thymoglobulin, as GvHD Prophylaxis in Patients Undergoing Related Donor HCT

Who this might be right for
Hematological Malignancies
Barbara Ann Karmanos Cancer Institute 21
Large-scale testing (Phase 3)Ended earlyNCT00607152
What this trial is testing

Rasburicase (Fasturtec) Registration Trial

Who this might be right for
Hyperuricemia
Sanofi 10
Testing effectiveness (Phase 2)Study completedNCT02661035
What this trial is testing

Allo HSCT Using RIC for Hematological Diseases

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+15 more
Masonic Cancer Center, University of Minnesota 156
Early research (Phase 1)UnknownNCT06008405
What this trial is testing

Clinical Trial Evaluating the Safety of the TQB2928 Injection Combination Therapy

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 48
Testing effectiveness (Phase 2)Study completedNCT00533078
What this trial is testing

Lipid Use, Nutrition, and Colitis in Patients With Hematological Malignancies

Who this might be right for
ColitisMucositisAML
Insel Gruppe AG, University Hospital Bern 14
Very early researchUnknownNCT04226989
What this trial is testing

CT-RD06 Cell Injection in Patients With Relapsed or Refractory CD19+ B-cell Hematological Malignancy

Who this might be right for
Acute Lymphoblastic LeukemiaNon-Hodgkin's Lymphoma
He Huang 72
Testing effectiveness (Phase 2)Ended earlyNCT00695370
What this trial is testing

Evaluation of Pegfilgrastim for Stem Cell Mobilization in Children

Who this might be right for
Solid Malignancies
University Hospital, Clermont-Ferrand 30
Not applicableNot Yet RecruitingNCT07343687
What this trial is testing

Clinico-hematological and Coagulation Profiles in Newly Diagnosed Acute Myeloid Leukemia Patients Treated With Intensive Induction Chemotherapy .

Who this might be right for
Acute Myeloid Leukemia
Assiut University 80
Early research (Phase 1)Study completedNCT05599932
What this trial is testing

Pharmacokinetics and Safety Study of Siremadlin (HDM201) in Participants With Mild, Moderate and Severe Hepatic Impairment

Who this might be right for
Hepatic Impairment
Novartis Pharmaceuticals 38
Early research (Phase 1)Study completedNCT00904787
What this trial is testing

Study of ENMD-2076 in Patients With Relapsed or Refractory Hematological Malignancies

Who this might be right for
Relapsed or Refractory Hematological Malignancies
CASI pharmaceuticals, Inc. 27
Not applicableUnknownNCT02300571
What this trial is testing

Observational Study of the Combination of Post-transplant High Dose Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Acute Graft-versus-Host Disease in Patients Eligible to Allogeneic Hematopoietic Stem Cell Transplant

Who this might be right for
Hematological Malignancies
Fondazione del Piemonte per l'Oncologia 60
Not applicableStudy completedNCT04764695
What this trial is testing

Body Composition and Nutritional Status in Pediatric Patients With Hematological Malignancies

Who this might be right for
Childhood CancerChild MalnutritionChildhood Obesity
Universidad de Sonora 38
Not applicableNot Yet RecruitingNCT07456189
What this trial is testing

The Efficacy and Safety of Stereotactic Radiotherapy Bridging Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Malignance Patients With Extramedullary Infiltrating

Who this might be right for
HSCTHematologic Cancer
Institute of Hematology & Blood Diseases Hospital, China 20
Not applicableLooking for participantsNCT06607289
What this trial is testing

National Longitudinal Cohort of Hematological Diseases (NICHE) - CART

Who this might be right for
Hematological Malignancies
Institute of Hematology & Blood Diseases Hospital, China 1,000
Not applicableStudy completedNCT04884204
What this trial is testing

Systematic Symptom Identification With Disease Specific PROM to Assess Symptoms of Chronic GVHD in Outpatient Care in Patients Post HSCT

Who this might be right for
GVHD, ChronicHematological Malignancy
Rigshospitalet, Denmark 35
Not applicableStudy completedNCT01576653
What this trial is testing

Prospective Clinical Evaluation of Beta-D-Glucan Assay in Blood and BAL

Who this might be right for
Invasive Fungal InfectionHematological MalignancyReceipt of Solid Organ Transplant
Robert Krause, MD 100
Very early researchLooking for participantsNCT04603872
What this trial is testing

CAR-T Cells Combined With Dasatinib for Patients With Relapsed and/or Refractory B-cell Hematological Malignancies

Who this might be right for
Multiple Myeloma in RelapseMultiple Myeloma, RefractoryAcute Lymphoblastic Leukemia, in Relapse+3 more
Zhejiang University 120
Large-scale testing (Phase 3)Study completedNCT03275636
What this trial is testing

Haploidentical Donor vs mMUD in Hematological Malignancies

Who this might be right for
AMLALLMDS
DKMS gemeinnützige GmbH 98
Next Page